Healthcare - Medical - Pharmaceuticals - NASDAQ - US
$ 25.3
-0.472 %
$ 1.83 B
Market Cap
None
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--
EBIT
Estimate
--
Net Income
Estimate
--
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Harrow Health, Inc. 8.625% Senior Notes due 2026
HROWL has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart HROWL
HROWL has no estimates for Revenue Forecast.
EBIT FORECAST
EBIT Forecast Chart HROWL
HROWL has no estimates for EBIT Forecast.
NET INCOME FORECAST
Net Income Chart HROWL
HROWL has no estimates for Net Income.